New Zealand markets open in 7 hours 13 minutes

Bayer Aktiengesellschaft (BAYN.DE)

XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
57.22+0.50 (+0.88%)
At close: 5:35PM CEST
Full screen
Previous close56.72
Open56.83
Bid57.28 x 28400
Ask57.30 x 2100
Day's range56.64 - 57.70
52-week range44.85 - 78.34
Volume7,344,395
Avg. volume3,144,229
Market cap56.489B
Beta (5Y monthly)1.23
PE ratio (TTM)N/A
EPS (TTM)-5.72
Earnings date03 Nov 2020
Forward dividend & yield2.80 (4.94%)
Ex-dividend date29 Apr 2020
1y target est120.99
  • GlobeNewswire

    BAYRY DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Bayer Aktiengesellschaft Shareholders With Losses Exceeding $2 Million of Class Action and Lead Plaintiff Deadline: September 14, 2020

    NEW YORK, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Bayer Aktiengesellschaft (“Bayer” or the “Company”) (OTC: BAYRY, BAYZF) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired PlayAGS securities between May 23, 2016 and March 19, 2019, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/bayry.This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose that material adverse facts. Specifically the complaint alleges that defendants willfully or recklessly made and/or caused the Company to make false and misleading statements that failed to disclose that the Monsanto acquisition would burden Bayer with significant exposure to the risk of suffering billions of dollars in judgments and reputational damage, among other things, if lawsuits brought against Monsanto alleging that exposure to its glyphosate-based Roundup product caused cancer, were successful. As a result, defendants’ positive statements about the prospects of the Monsanto acquisition and the benefits it would create for Bayer’s business were materially false and/or misleading and/or lacked a reasonable basis.A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com/bayry or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Bayer you have until September 14, 2020 to request that the Court appoint you as lead plaintiff.  Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz 212-697-6484 | info@bgandg.com

  • DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Bayer Aktiengesellschaft and Encourages Investors with Losses of $100,000 to Contact the Firm
    Business Wire

    DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Bayer Aktiengesellschaft and Encourages Investors with Losses of $100,000 to Contact the Firm

    DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Bayer Aktiengesellschaft.

  • GlobeNewswire

    FINAL DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, Reminds Bayer Aktiengesellschaft Investors of Important Monday Deadline in Securities Class Action – BAYRY, BAYZF

    NEW YORK, Sept. 13, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Bayer Aktiengesellschaft (OTC: BAYRY, BAYZF) between May 23, 2016 and March 19, 2019, inclusive (the “Class Period”), of the important September 14, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Bayer investors under the federal securities laws. To join the Bayer class action, go to http://www.rosenlegal.com/cases-register-1899.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR’S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF. According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose: (1) that the acquisition of Monsanto Company would burden Bayer with significant exposure to the risk of suffering billions of dollars in judgments and reputational damage, among other things, if lawsuits brought against Monsanto alleging that exposure to its glyphosate-based Roundup product caused cancer, were successful; and (2) as a result, defendants’ positive statements about the prospects of the Monsanto acquisition and the benefits it would create for Bayer’s business were materially false and/or misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 14, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-register-1899.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or cases@rosenlegal.com.Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors. Attorney Advertising. Prior results do not guarantee a similar outcome.Contact Information:       Laurence Rosen, Esq.       Phillip Kim, Esq.       The Rosen Law Firm, P.A.       275 Madison Avenue, 40th Floor       New York, NY 10016       Tel: (212) 686-1060       Toll Free: (866) 767-3653       Fax: (212) 202-3827       lrosen@rosenlegal.com       pkim@rosenlegal.com       cases@rosenlegal.com       www.rosenlegal.com